Loading data for HQL — first visit, this takes a few seconds.
Abrdn Life Sciences Inves... (HQL)
NYSE: HQL
· Precio en tiempo real · USD
21.72
+0.35 (1.64%)
Al cierre: Aug 18, 2026, 3:59 PM
21.72
+0.00%
Premercado: 5:53 AM
Abrdn Life Sciences Investors (HQL) Stock Price, Analysis & Data
1.64% (1D)
| Precio de compra | n/a |
| Capitalización de mercado | 660.46M |
| Ingresos (TTM) | 1.11M |
| Beneficio neto (TTM) | 198.17M |
| Beta | 0.71 |
| EPS (TTM) | 6.75 |
| Ratio PER (TTM) | 3.27 |
| Adelante PE | n/a |
| P/B (TTM) | 1.18 |
| P/S (TTM) | 595.14 |
| Earnings Date | n/a |
| Precio de venta | n/a |
| Volumen | 169,718 |
| Volumen medio (20D) | 142,743 |
| Abierto | 21.39 |
| Anterior Cerrar | 21.37 |
| Rango del día | 21.19 - 21.72 |
| Rango de 52 semanas | 13.57 - 21.72 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | $2.24 (10.48%) |
| Fecha ex dividendo | 24 ago 2026 |
Acerca de HQL
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture...
Industria Asset Management
Sector Financial Services
IPO Fecha May 1, 1992
Empleados n/a
Bolsa de Valores NYSE
Símbolo bursátil HQL
Desempeño financiero
En 2025, los ingresos de Abrdn Life Sciences Investors fueron 86.39M, una disminución de -0.35% en comparación con 86.69M del año anterior. Las ganancias fueron 85.59M, un aumento de 0.35%.
Estados financieros